Mastitis due to Mycobacterium avium complex in an HIV-infected woman taking highly active antiretroviral therapy

被引：5

作者：

Cunningham, CO

Selwyn, PA

机构：

[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA

[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Family & Community Hlth, Bronx, NY 10467 USA

来源：

AIDS PATIENT CARE AND STDS | 2003年 / 17卷 / 11期

关键词：

D O I：

10.1089/108729103322555935

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Although infection with Mycobacterium avium complex (MAC) is common in HIV-infected patients with CD4(+) T cell counts less than 100/mm(3), localized infection of the breast is uncommon. A brief literature review of mastitis from atypical mycobacteria is presented, along with the first reported case of localized MAC infection of the nonaugmented breast in an HIV-infected woman taking highly active antiretroviral therapy.

引用

页码：547 / 550

页数：4

共 50 条

[21] Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy
Foulon, G
Wislez, M
Naccache, JM
Blanc, FX
Rabbat, A
Israël-Biet, D
Valeyre, D
Mayaud, C
Cadranel, J
CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 418 - 425
[22] Hospitalized HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy
Metsch, Lisa R.
Bell, Christine
Pereyra, Margaret
Cardenas, Gabriel
Sullivan, Tanisha
Rodriguez, Allan
Gooden, Lauren
Khoury, Nayla
Kuper, Tamy
Brewer, Toye
del Rio, Carlos
AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 99 (06) : 1045 - 1049
[23] Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy
Markert, ML
Alvarez-McLeod, AP
Sempowski, GD
Hale, LP
Horvatinovich, JM
Weinhold, KJ
Bartlett, JA
D'Amico, TA
Haynes, BF
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (17) : 1635 - 1643
[24] Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients
Sendi, PP
Bucher, HC
Harr, T
Craig, BA
Schwietert, M
Pfluger, D
Gafni, A
Battegay, M
AIDS, 1999, 13 (09) : 1115 - 1122
[25] Cardiovascular disease in HIV-infected patients on highly active antiretroviral therapy
Jericó, C
Knobel, H
Carmona, A
Sorli, ML
López-Colomés, JL
Pedro-Botet, J
MEDICINA CLINICA, 2004, 122 (08): : 298 - 300
[26] Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients
Barbaro, G
Klatt, EC
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (18) : 1475 - 1481
[27] Autoimmune Diabetes in HIV-Infected Patients on Highly Active Antiretroviral Therapy
Takarabe, Daisuke
Rokukawa, Yuka
Takahashi, Yoshihiko
Goto, Atsushi
Takaichi, Maki
Okamoto, Masahide
Tsujimoto, Tetsuro
Noto, Hiroshi
Kishimoto, Miyako
Kaburagi, Yasushi
Yasuda, Kazuki
Yamamoto-Honda, Ritsuko
Tsukada, Kunihisa
Honda, Miwako
Teruya, Katsuji
Kajio, Hiroshi
Kikuchi, Yoshimi
Oka, Shinichi
Noda, Mitsuhiko
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (08): : 4056 - 4060
[28] Dyspepsia in HIV-infected patients under highly active antiretroviral therapy
Werneck-Silva, Ana Luiza
Prado, Ivete Bedin
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (11) : 1712 - 1716
[29] Anemia in HIV-infected patients receiving highly active antiretroviral therapy
Moore, RD
Forney, D
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (01) : 54 - 57
[30] Osteopenia in HIV-infected women prior to highly active antiretroviral therapy
Teichmann, J
Stephan, E
Lange, U
Discher, T
Friese, G
Lohmeyer, J
Stracke, H
Bretzel, RG
JOURNAL OF INFECTION, 2003, 46 (04) : 221 - 227

← 1 2 3 4 5 →